{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T16:02:54Z","timestamp":1783958574880,"version":"3.55.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}],"id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Institut Curie Siric 2","award":["INCa-DGOS-4654"],"award-info":[{"award-number":["INCa-DGOS-4654"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Breast Cancer Res"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Cancer-related microangiopathic haemolytic anaemia (MAHA) is a rare but life-threatening paraneoplastic syndrome. Only single cases or small series have been reported to date. We set up a retrospective multicentre study focusing on breast cancer-related MAHA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Main inclusion criteria were known diagnosis of breast cancer, presence of schistocytes and either low haptoglobin or cytopenia and absence of any causes of MAHA other than breast cancer, including gemcitabine- or bevacizumab-based treatment. Patient characteristics, treatments and outcome were retrieved from digital medical records.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Individual data from 54 patients with breast cancer-related MAHA were obtained from 7 centres. Twenty-three (44%) patients had a breast tumour with lobular features, and most primary tumours were low grade (grade I\/II,<jats:italic>N<\/jats:italic>\u00a0=\u200939, 75%). ER+\/HER2\u2212, HER2+ and triple-negative phenotypes accounted for<jats:italic>N<\/jats:italic>\u00a0=\u200933 (69%),<jats:italic>N<\/jats:italic>\u00a0=\u20097 (15%) and<jats:italic>N<\/jats:italic>\u00a0=\u20098 (17%) cases, respectively. All patients had stage IV cancer at the time of MAHA diagnosis. Median overall survival (OS) was 28\u2009days (range 0\u20131035; Q1:10, Q3:186). Independent prognostic factors for early death (\u2264\u200928\u2009days) were PS\u2009&gt;\u20092 (OR\u2009=\u20097.0 [1.6; 31.8]), elevated bilirubin (OR\u2009=\u20096.9 [1.1; 42.6]), haemoglobin &lt;\u20098.0\u2009g\/dL (OR\u2009=\u20093.7 [0.9; 16.7]) and prothrombin time\u2009&lt;\u200950% (OR\u2009=\u20099.1 [1.2; 50.0]). A score to predict early death displayed a sensitivity of 86% (95% CI [0.67; 0.96]), a specificity of 73% (95% CI [0.52; 0.88]) and an area under the curve of 0.90 (95% CI [0.83; 0.97]).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Breast cancer-related MAHA appears to be a new feature of invasive lobular breast carcinoma. Prognostic factors and scores may guide clinical decision-making in this serious but not always fatal condition.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13058-021-01386-y","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T09:02:51Z","timestamp":1611046971000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Characteristics and outcome of breast cancer-related microangiopathic haemolytic anaemia: a multicentre study"],"prefix":"10.1186","volume":"23","author":[{"given":"Marion","family":"Alhenc-Gelas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Cabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederique","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzette","family":"Delaloge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Sebastien","family":"Frenel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelly","family":"Firmin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvain","family":"Ladoire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Desmoulins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Etienne","family":"Heudel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Dalenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Loirat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coraline","family":"Dubot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Perrine","family":"Vuagnat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Deluche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meriem","family":"Mokdad-Adi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Patsouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josselin","family":"Annic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lounes","family":"Djerroudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Lavigne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Yves","family":"Pierga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Coppo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5932-8949","authenticated-orcid":false,"given":"Francois-Clement","family":"Bidard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"7","key":"1386_CR1","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1056\/NEJMra1312353","volume":"371","author":"JN George","year":"2014","unstructured":"George JN, Nester CM. Syndromes of thrombotic microangiopathy. N Engl J Med. 2014;371(7):654\u201366.","journal-title":"N Engl J Med"},{"issue":"5","key":"1386_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1097\/00005792-197909000-00004","volume":"58","author":"KH Antman","year":"1979","unstructured":"Antman KH, Skarin AT, Mayer RJ, Hargreaves HK, Canellos GP. Microangiopathic hemolytic anemia and cancer: a review. Medicine (Baltimore). 1979;58(5):377\u201384.","journal-title":"Medicine (Baltimore)"},{"issue":"4","key":"1386_CR3","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1111\/j.1365-2141.1962.tb06541.x","volume":"8","author":"MC Brain","year":"1962","unstructured":"Brain MC, Dacie JV, Hourihane DO. Microangiopathic haemolytic anaemia: the possible role of vascular lesions in pathogenesis. Br J Haematol. 1962;8(4):358\u201374.","journal-title":"Br J Haematol"},{"issue":"1\u20136","key":"1386_CR4","first-page":"6","volume":"10","author":"HH Versteeg","year":"2004","unstructured":"Versteeg HH, Spek CA, Peppelenbosch MP, Richel DJ. Tissue factor and cancer metastasis: the role of intracellular and extracellular signaling pathways. Mol Med Camb Mass. 2004;10(1\u20136):6\u201311.","journal-title":"Mol Med Camb Mass"},{"issue":"4","key":"1386_CR5","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1002\/ajh.20783","volume":"82","author":"TL Werner","year":"2007","unstructured":"Werner TL, Agarwal N, Carney HM, Rodgers GM. Management of cancer-associated thrombotic microangiopathy: what is the right approach? Am J Hematol. 2007;82(4):295\u20138.","journal-title":"Am J Hematol"},{"issue":"22","key":"1386_CR6","doi-asserted-by":"publisher","first-page":"6830","DOI":"10.1158\/1078-0432.CCR-09-0371","volume":"15","author":"JI Zwicker","year":"2009","unstructured":"Zwicker JI, Liebman HA, Neuberg D, Lacroix R, Bauer KA, Furie BC, et al. Tumor-derived tissue factor-bearing microparticles are associated with venous thromboembolic events in malignancy. Clin Cancer Res Off J Am Assoc Cancer Res. 2009;15(22):6830\u201340.","journal-title":"Clin Cancer Res Off J Am Assoc Cancer Res"},{"issue":"2","key":"1386_CR7","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1159\/000366474","volume":"7","author":"S Marumo","year":"2014","unstructured":"Marumo S, Sakaguchi M, Teranishi T, Higami Y, Koshimo Y, Kato M. Pulmonary tumor thrombotic microangiopathy induced by ureteral carcinoma: a necropsy case report. Case Rep Oncol. 2014;7(2):605\u201310.","journal-title":"Case Rep Oncol"},{"issue":"9","key":"1386_CR8","first-page":"2244","volume":"59","author":"L Oleksowicz","year":"1999","unstructured":"Oleksowicz L, Bhagwati N, DeLeon-Fernandez M. Deficient activity of von Willebrand\u2019s factor-cleaving protease in patients with disseminated malignancies. Cancer Res. 1999;59(9):2244\u201350.","journal-title":"Cancer Res"},{"issue":"6","key":"1386_CR9","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1172\/JCI200318882","volume":"112","author":"M Wahrenbrock","year":"2003","unstructured":"Wahrenbrock M, Borsig L, Le D, Varki N, Varki A. Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas. J Clin Invest. 2003;112(6):853\u201362.","journal-title":"J Clin Invest"},{"issue":"4","key":"1386_CR10","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1097\/MD.0b013e3182603598","volume":"91","author":"K Lechner","year":"2012","unstructured":"Lechner K, Obermeier HL. Cancer-related microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases. Medicine (Baltimore). 2012;91(4):195\u2013205.","journal-title":"Medicine (Baltimore)"},{"issue":"3","key":"1386_CR11","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1111\/j.1365-2141.2008.07575.x","volume":"146","author":"A Himmelmann","year":"2009","unstructured":"Himmelmann A, Schefer H. Microangiopathic haemolytic anaemia in a patient with metastatic breast cancer. Br J Haematol. 2009;146(3):231.","journal-title":"Br J Haematol"},{"issue":"4","key":"1386_CR12","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1002\/(SICI)1096-8652(199908)61:4<254::AID-AJH5>3.0.CO;2-C","volume":"61","author":"KI Ataga","year":"1999","unstructured":"Ataga KI, Graham ML. Microangiopathic hemolytic anemia associated with metastatic breast carcinoma. Am J Hematol. 1999;61(4):254\u20135.","journal-title":"Am J Hematol"},{"issue":"2","key":"1386_CR13","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2141.1970.tb01433.x","volume":"18","author":"MC Brain","year":"1970","unstructured":"Brain MC, Azzopardi JG, Baker LR, Pineo GF, Roberts PD, Dacie JV. Microangiopathic haemolytic anaemia and mucin-forming adenocarcinoma. Br J Haematol. 1970;18(2):183\u201393.","journal-title":"Br J Haematol"},{"issue":"6","key":"1386_CR14","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1159\/000335201","volume":"6","author":"AC Regierer","year":"2011","unstructured":"Regierer AC, Kuehnhardt D, Schulz C-O, Flath B, Jehn CF, Scholz CW, et al. Breast cancer-associated thrombotic microangiopathy. Breast Care. 2011;6(6):441\u20135.","journal-title":"Breast Care"},{"key":"1386_CR15","unstructured":"Coppo P, Veyradier A, Chantal Loirat C. Microangiopathies thrombotiques. R\u00e9f\u00e9rentiels H\u00e9mostase\/Soci\u00e9t\u00e9 Fran\u00e7aise d\u2019H\u00e9matologie [Internet]."},{"issue":"8","key":"1386_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1056\/NEJMra020528","volume":"347","author":"JL Moake","year":"2002","unstructured":"Moake JL. Thrombotic microangiopathies. N Engl J Med. 2002;347(8):589\u2013600.","journal-title":"N Engl J Med"},{"issue":"15","key":"1386_CR17","doi-asserted-by":"publisher","first-page":"2538","DOI":"10.1200\/JCO.2007.14.9518","volume":"26","author":"A-C Barbot","year":"2008","unstructured":"Barbot A-C, Mussault P, Ingrand P, Tourani J-M. Assessing 2-month clinical prognosis in hospitalized patients with advanced solid tumors. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26(15):2538\u201343.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"1386_CR18","unstructured":"Harrell FE Jr Hmisc: Harrell Miscellaneous. R package version 4.2\u20130 [Internet]. 2019. Disponible sur: https:\/\/CRAN.R-project.org\/package=Hmisc"},{"key":"1386_CR19","volume-title":"Regression Modeling Strategies. R package version 5.1\u20133.1. [Internet]","author":"FE Harrell Jr","year":"2019","unstructured":"Harrell FE Jr. Regression Modeling Strategies. R package version 5.1\u20133.1. [Internet]. 2019. Disponible sur: https:\/\/CRAN.R-project.org\/package=rms"},{"key":"1386_CR20","volume-title":"ROCit: Performance Assessment of Binary Classifier with Visualization. R package version 1.1.1. [Internet]","author":"MRA Khan","year":"2019","unstructured":"Md Riaz Ahmed Khan and Thomas Brandenburger. ROCit: Performance Assessment of Binary Classifier with Visualization. R package version 1.1.1. [Internet]. 2019. Disponible sur: https:\/\/CRAN.R-project.org\/package=ROCit"},{"issue":"1","key":"1386_CR21","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","volume":"145","author":"M Levi","year":"2009","unstructured":"Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol. 2009;145(1):24\u201333.","journal-title":"Br J Haematol"},{"key":"1386_CR22","first-page":"17","volume":"96","author":"E Gobbini","year":"2018","unstructured":"Gobbini E, Ezzalfani M, Dieras V, Bachelot T, Brain E, Debled M, et al. Time trends of overall survival among metastatic breast cancer patients in the real-life ESME cohort. Eur J Cancer Oxf Engl 1990. 2018;96:17\u201324.","journal-title":"Eur J Cancer Oxf Engl 1990"},{"issue":"1","key":"1386_CR23","doi-asserted-by":"publisher","first-page":"684","DOI":"10.1186\/s40064-016-2312-4","volume":"5","author":"D Takabatake","year":"2016","unstructured":"Takabatake D, Oishi K. Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature review. SpringerPlus. 2016;5(1):684.","journal-title":"SpringerPlus."},{"issue":"3","key":"1386_CR24","first-page":"279","volume":"63","author":"J-F Lesesve","year":"2005","unstructured":"Lesesve J-F, Lecompte T, Alla F, Fenneteau O, Cynober T, Siest J-P, et al. Reproductibility of the morphological identification of schisocytes and evaluation of non observer-dependent methods. Ann Biol Clin (Paris). 2005;63(3):279\u201389.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"5","key":"1386_CR25","first-page":"605","volume":"70","author":"J-F Lesesve","year":"2012","unstructured":"Lesesve J-F, Crepin O, Siest J-P, R\u00e9gnier F, Zeltner S. Evaluation of schistocytes measurement guidelines. Ann Biol Clin (Paris). 2012;70(5):605\u201313.","journal-title":"Ann Biol Clin (Paris)"},{"issue":"11","key":"1386_CR26","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1093\/annonc\/mdq232","volume":"21","author":"H Gauthier","year":"2010","unstructured":"Gauthier H, Guilhaume MN, Bidard FC, Pierga JY, Girre V, Cottu PH, et al. Survival of breast cancer patients with meningeal carcinomatosis. Ann Oncol. 2010;21(11):2183\u20137.","journal-title":"Ann Oncol"},{"issue":"1","key":"1386_CR27","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1007\/s12032-012-0408-4","volume":"30","author":"A Niwi\u0144ska","year":"2013","unstructured":"Niwi\u0144ska A, Rudnicka H, Murawska M. Breast cancer leptomeningeal metastasis: propensity of breast cancer subtypes for leptomeninges and the analysis of factors influencing survival. Med Oncol Northwood Lond Engl. 2013;30(1):408.","journal-title":"Med Oncol Northwood Lond Engl"},{"issue":"3","key":"1386_CR28","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.critrevonc.2014.07.003","volume":"92","author":"S Guiu","year":"2014","unstructured":"Guiu S, Wolfer A, Jacot W, Fumoleau P, Romieu G, Bonnetain F, et al. Invasive lobular breast cancer and its variants: how special are they for systemic therapy decisions? Crit Rev Oncol Hematol. 2014;92(3):235\u201357.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"1","key":"1386_CR29","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s10689-007-9172-6","volume":"7","author":"KA Schrader","year":"2008","unstructured":"Schrader KA, Masciari S, Boyd N, Wiyrick S, Kaurah P, Senz J, et al. Hereditary diffuse gastric cancer: association with lobular breast cancer. Familial Cancer. 2008;7(1):73\u201382.","journal-title":"Familial Cancer"},{"issue":"1","key":"1386_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00005792-197756010-00001","volume":"56","author":"GH Sack","year":"1977","unstructured":"Sack GH, Levin J, Bell WR. Trousseau\u2019s syndrome and other manifestations of chronic disseminated coagulopathy in patients with neoplasms: clinical, pathophysiologic, and therapeutic features. Medicine (Baltimore). 1977;56(1):1\u201337.","journal-title":"Medicine (Baltimore)"},{"issue":"1","key":"1386_CR31","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1634\/theoncologist.12-1-11","volume":"12","author":"KK Francis","year":"2007","unstructured":"Francis KK, Kalyanam N, Terrell DR, Vesely SK, George JN. Disseminated malignancy misdiagnosed as thrombotic thrombocytopenic purpura: a report of 10 patients and a systematic review of published cases. The Oncologist. 2007;12(1):11\u20139.","journal-title":"The Oncologist"},{"issue":"3","key":"1386_CR32","doi-asserted-by":"publisher","first-page":"368","DOI":"10.7326\/0003-4819-79-3-368","volume":"79","author":"H-P Lohrmann","year":"1973","unstructured":"Lohrmann H-P. Microangiopathic hemolytic anemia in metastatic carcinoma: report of eight cases. Ann Intern Med. 1973;79(3):368.","journal-title":"Ann Intern Med"},{"issue":"1","key":"1386_CR33","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1046\/j.1365-2141.2001.02704.x","volume":"113","author":"S Fontana","year":"2001","unstructured":"Fontana S, Gerritsen HE, Kremer Hovinga J, Furlan M, L\u00e4mmle B. Microangiopathic haemolytic anaemia in metastasizing malignant tumours is not associated with a severe deficiency of the von Willebrand factor-cleaving protease. Br J Haematol. 2001;113(1):100\u20132.","journal-title":"Br J Haematol"},{"issue":"8","key":"1386_CR34","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1634\/theoncologist.2009-0067","volume":"14","author":"L Oberic","year":"2009","unstructured":"Oberic L, Buffet M, Schwarzinger M, Veyradier A, Clabault K, Malot S, et al. Cancer awareness in atypical thrombotic microangiopathies. The Oncologist. 2009;14(8):769\u201379.","journal-title":"The Oncologist"},{"issue":"6","key":"1386_CR35","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1097\/00007611-199506000-00021","volume":"88","author":"YC Lin","year":"1995","unstructured":"Lin YC, Chang HK, Sun CF, Shih LY. Microangiopathic hemolytic anemia as an initial presentation of metastatic cancer of unknown primary origin. South Med J. 1995;88(6):683\u20137.","journal-title":"South Med J"},{"issue":"6","key":"1386_CR36","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/annonc\/mdn160","volume":"19","author":"I Spoormans","year":"2008","unstructured":"Spoormans I, Altintas S, Van den Brande J, Luijks A, Vermorken JB. Purpura in a patient with disseminated breast cancer: a rapidly progressive cancer-related thrombotic thrombocytopenic purpura. Ann Oncol Off J Eur Soc Med Oncol. 2008;19(6):1204\u20137.","journal-title":"Ann Oncol Off J Eur Soc Med Oncol"},{"issue":"3","key":"1386_CR37","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1159\/000069291","volume":"109","author":"RB Forman","year":"2003","unstructured":"Forman RB, Benkel SA, Novik Y, Tsai H-M. Presence of ADAMTS13 activity in a patient with metastatic cancer and thrombotic microangiopathy. Acta Haematol. 2003;109(3):150\u20132.","journal-title":"Acta Haematol"},{"issue":"4","key":"1386_CR38","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1634\/theoncologist.8-4-375","volume":"8","author":"JC Chang","year":"2003","unstructured":"Chang JC, Naqvi T. Thrombotic thrombocytopenic purpura associated with bone marrow metastasis and secondary myelofibrosis in cancer. Oncologist. 2003;8(4):375\u201380.","journal-title":"Oncologist"},{"issue":"4","key":"1386_CR39","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1111\/jth.12838","volume":"13","author":"J Thachil","year":"2015","unstructured":"Thachil J, Falanga A, Levi M, Liebman H, Di Nisio M. Management of cancer-associated disseminated intravascular coagulation: guidance from the SSC of the ISTH. J Thromb Haemost. 2015;13(4):671\u20135.","journal-title":"J Thromb Haemost"},{"issue":"2","key":"1386_CR40","first-page":"172","volume":"17","author":"RW Colman","year":"1990","unstructured":"Colman RW, Rubin RN. Disseminated intravascular coagulation due to malignancy. Semin Oncol. 1990;17(2):172\u201386.","journal-title":"Semin Oncol"},{"issue":"11","key":"1386_CR41","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1016\/j.revmed.2017.06.025","volume":"38","author":"P Coppo","year":"2017","unstructured":"Coppo P. Microangiopathies thrombotiques secondaires. Rev M\u00e9d Interne. 2017;38(11):731\u20136.","journal-title":"Rev M\u00e9d Interne"},{"issue":"1","key":"1386_CR42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1600-0609.2010.01448.x","volume":"85","author":"MA Elliott","year":"2010","unstructured":"Elliott MA, Letendre L, Gastineau DA, Winters JL, Pruthi RK, Heit JA. Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration. Eur J Haematol. 2010;85(1):43\u201350.","journal-title":"Eur J Haematol"},{"issue":"1","key":"1386_CR43","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1097\/00000421-200002000-00021","volume":"23","author":"N von Bubnoff","year":"2000","unstructured":"von Bubnoff N, Sandherr M, Schneller F, Peschel C. Thrombotic thrombocytopenic purpura in metastatic carcinoma of the breast. Am J Clin Oncol. 2000;23(1):74\u20137.","journal-title":"Am J Clin Oncol"},{"issue":"3","key":"1386_CR44","first-page":"148","volume":"99","author":"A Abdel Samie","year":"2004","unstructured":"Abdel Samie A, Sandritter B, Theilmann L. Severe microangiopathic hemolytic anemia as first manifestation of a CUP syndrome. Rapid hematologic remission under polychemotherapy. Med Klin Munich Ger 1983. 2004;99(3):148\u201353.","journal-title":"Med Klin Munich Ger 1983"},{"issue":"1","key":"1386_CR45","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/BF02967054","volume":"4","author":"M Narita","year":"1997","unstructured":"Narita M, Nakao K, Ogino N, Emoto T, Nakahara M, Yumiba T, et al. A case of microangiopathic hemolytic anemia associated with breast cancer: improvement with chemoendocrine therapy. Breast Cancer Tokyo Jpn. 1997;4(1):39\u201342.","journal-title":"Breast Cancer Tokyo Jpn"}],"container-title":["Breast Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-021-01386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13058-021-01386-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13058-021-01386-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,22]],"date-time":"2024-08-22T16:45:14Z","timestamp":1724345114000},"score":1,"resource":{"primary":{"URL":"https:\/\/breast-cancer-research.biomedcentral.com\/articles\/10.1186\/s13058-021-01386-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["1386"],"URL":"https:\/\/doi.org\/10.1186\/s13058-021-01386-y","relation":{},"ISSN":["1465-542X"],"issn-type":[{"value":"1465-542X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"24 August 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the <i>Institut Curie<\/i> review board; a waiver of informed consent was granted because of the retrospective nature of the work.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9"}}